National Healthcare(DE:HTW)
€183.00-1.00 (-0.54%)
DE:HTW
National Healthcare financials statements
€183.00
At close:-1.00 (-0.54%)
National Healthcare (HTW) Ratios
0 Followers
National Healthcare Ratios
DE:HTW's free cash flow for Q3 2026 was $85.66M. For the 2026 fiscal year, DE:HTW's free cash flow was decreased by $-13.49M and operating cash flow was $99.15M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.77 | 1.81 | 1.89 | 1.79 | 1.62 |
| Quick Ratio | 1.77 | 1.77 | 1.86 | 1.75 | 1.59 |
| Cash Ratio | 0.44 | 0.32 | 0.50 | 0.30 | 0.41 |
| Solvency Ratio | 0.36 | 0.27 | 0.27 | 0.16 | 0.36 |
| Operating Cash Flow Ratio | 0.73 | 0.46 | 0.52 | 0.04 | 0.24 |
| Short-Term Operating Cash Flow Coverage | 4.50 | 14.31 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -3.72M | $ -116.86M | $ 5.92M | $ -44.00M | $ -68.30M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.14 | 0.07 | 0.10 | 0.12 |
| Debt-to-Equity Ratio | 0.08 | 0.22 | 0.10 | 0.14 | 0.18 |
| Debt-to-Capital Ratio | 0.08 | 0.18 | 0.09 | 0.13 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.12 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.43 | 1.56 | 1.44 | 1.46 | 1.55 |
| Debt Service Coverage Ratio | 3.66 | 12.74 | 332.24 | 108.40 | 213.73 |
| Interest Coverage Ratio | 20.15 | 20.74 | 176.34 | 56.65 | 60.27 |
| Debt to Market Cap | 0.03 | 0.08 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 6.04 | 14.22 | 6.12 | 8.21 | 10.91 |
| Net Debt to EBITDA | -0.11 | 0.76 | -0.10 | 0.99 | 0.31 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.31% | 37.52% | 37.60% | 36.13% | 34.11% |
| EBIT Margin | 11.12% | 10.83% | 7.80% | 2.59% | 14.92% |
| EBITDA Margin | 14.08% | 14.06% | 11.48% | 6.36% | 18.95% |
| Operating Profit Margin | 8.46% | 6.61% | 5.00% | 2.97% | 5.04% |
| Pretax Profit Margin | 10.70% | 10.51% | 7.77% | 2.53% | 14.84% |
| Net Profit Margin | 7.91% | 7.85% | 5.85% | 2.09% | 13.71% |
| Continuous Operations Profit Margin | 8.08% | 7.87% | 5.72% | 1.86% | 13.76% |
| Net Income Per EBT | 73.89% | 74.72% | 75.28% | 82.42% | 92.37% |
| EBT Per EBIT | 126.55% | 159.06% | 155.32% | 85.37% | 294.63% |
| Return on Assets (ROA) | 7.86% | 6.69% | 5.10% | 1.76% | 9.88% |
| Return on Equity (ROE) | 11.23% | 10.40% | 7.35% | 2.57% | 15.35% |
| Return on Capital Employed (ROCE) | 10.08% | 6.65% | 5.21% | 2.96% | 4.47% |
| Return on Invested Capital (ROIC) | 7.37% | 4.83% | 3.73% | 2.10% | 4.03% |
| Return on Tangible Assets | 8.98% | 7.64% | 5.88% | 2.04% | 11.29% |
| Earnings Yield | 5.66% | 6.16% | 4.72% | 2.45% | 13.29% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.92 | 9.56 | 10.47 | 10.71 | 10.47 |
| Payables Turnover | 40.46 | 31.81 | 37.11 | 40.46 | 29.62 |
| Inventory Turnover | 0.00 | 89.71 | 96.45 | 96.81 | 77.61 |
| Fixed Asset Turnover | 0.00 | 1.70 | 1.94 | 1.71 | 1.49 |
| Asset Turnover | 0.99 | 0.85 | 0.87 | 0.84 | 0.72 |
| Working Capital Turnover Ratio | 7.90 | 6.81 | 6.56 | 6.73 | 5.96 |
| Cash Conversion Cycle | 24.41 | 30.79 | 28.82 | 28.82 | 27.25 |
| Days of Sales Outstanding | 33.43 | 38.20 | 34.87 | 34.07 | 34.87 |
| Days of Inventory Outstanding | 0.00 | 4.07 | 3.78 | 3.77 | 4.70 |
| Days of Payables Outstanding | 9.02 | 11.47 | 9.83 | 9.02 | 12.32 |
| Operating Cycle | 33.43 | 42.27 | 38.65 | 37.84 | 39.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 11.96 | 6.97 | 7.26 | 0.57 | 4.07 |
| Free Cash Flow Per Share | 9.61 | 5.18 | 5.44 | -1.39 | 1.50 |
| Dividend Paid and CapEx Coverage Ratio | 2.46 | 1.66 | 1.75 | 0.13 | 0.87 |
| Capital Expenditure Coverage Ratio | 5.08 | 3.89 | 3.99 | 0.29 | 1.58 |
| Operating Cash Flow Coverage Ratio | 2.13 | 0.50 | 1.19 | 0.07 | 0.37 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.08 | 0.10 | 0.01 | 0.06 |
| Free Cash Flow Yield | 7.01% | 4.81% | 5.89% | -2.34% | 2.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.67 | 16.25 | 21.18 | 40.85 | 7.52 |
| Price-to-Sales (P/S) Ratio | 1.40 | 1.28 | 1.24 | 0.85 | 1.03 |
| Price-to-Book (P/B) Ratio | 1.98 | 1.69 | 1.56 | 1.05 | 1.15 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.27 | 20.77 | 16.98 | -42.73 | 45.34 |
| Price-to-Operating Cash Flow Ratio | 11.46 | 15.43 | 12.72 | 104.89 | 16.71 |
| Price-to-Earnings Growth (PEG) Ratio | 1.03 | 0.31 | 0.11 | -0.49 | 0.03 |
| Enterprise Value Multiple | 9.81 | 9.83 | 10.69 | 14.41 | 5.75 |
| Enterprise Value | 2.10B | 1.79B | 1.40B | 984.18M | 1.10B |
| EV to EBITDA | 9.81 | 9.83 | 10.69 | 14.41 | 5.75 |
| EV to Sales | 1.38 | 1.38 | 1.23 | 0.92 | 1.09 |
| EV to Free Cash Flow | 14.11 | 22.51 | 16.82 | -45.87 | 47.91 |
| EV to Operating Cash Flow | 11.33 | 16.72 | 12.60 | 112.58 | 17.66 |
| Tangible Book Value Per Share | 57.15 | 51.50 | 48.02 | 45.57 | 47.77 |
| Shareholders’ Equity Per Share | 69.08 | 63.67 | 59.36 | 56.73 | 58.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.25 | 0.26 | 0.27 | 0.07 |
| Revenue Per Share | 98.10 | 84.32 | 74.56 | 69.71 | 65.87 |
| Net Income Per Share | 7.76 | 6.62 | 4.36 | 1.46 | 9.03 |
| Tax Burden | 0.74 | 0.75 | 0.75 | 0.82 | 0.92 |
| Interest Burden | 0.96 | 0.97 | 1.00 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.51 | 1.05 | 1.70 | 0.44 | 0.45 |
Currency in USD
